FDA Approved: BOSULIF — Original Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approves BOSULIF (bosutinib) as the original application for Philadelphia chromosome-positive chronic myeloid leukemia in adults with resistance or intolera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• BOSULIF (bosutinib)

Snippet

ORIG AP for BOSULIF (BOSUTINIB)